Certara Supported 90+ Percent of US FDA Novel New Drug Approvals for Sixth Consecutive Year
PRINCETON, NJ – Jan. 23, 2020 – Certara today reported that more than 90% of novel new drug approvals by the US Food and Drug Administration (FDA) in 2019 were supported by Certara software or services.